Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jCell in Adult Subjects With Retinitis Pigmentosa
NCT03073733Phase 2Completed
- Sponsor
- jCyte, Inc.
- Start
- Mar 2017
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 2 trial of famzeretcel in retinitis pigmentosa (RP), sponsored by jCyte, Inc.. Started Mar 2017; status: completed.
02
Drugs
famzeretcel
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT03073733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073733.